The global market for Imipenem Astatin Sodium for Injection was valued at US$ 2672 million in the year 2024 and is projected to reach a revised size of US$ 3943 million by 2031, growing at a CAGR of 5.8% during the forecast period.

Imipenem Astatin Sodium for Injection Market

Imipenem and cilastatin are broad-spectrum antibiotics, suitable for mixed infections caused by various pathogens and aerobic/anaerobic bacteria, as well as early treatment before the pathogens are not identified.

North American market for Imipenem Astatin Sodium for Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Imipenem Astatin Sodium for Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Imipenem Astatin Sodium for Injection include MSD, Shandong New Era Pharmaceuticals, Shenzhen Haibin Pharmaceutical, Sinopharm Guorui Pharmaceutical, Merck Sharp & Dohme Corp., Taiwan Biotech Co., Ltd., Sun Pharmaceutical Industries Ltd., JW PHARMACEUTICAL CORPORATION, Gentle Pharma Co.,Ltd., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Imipenem Astatin Sodium for Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Imipenem Astatin Sodium for Injection.

The Imipenem Astatin Sodium for Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Imipenem Astatin Sodium for Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Imipenem Astatin Sodium for Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Imipenem Astatin Sodium for Injection Market Report

Report Metric	Details
Report Name	Imipenem Astatin Sodium for Injection Market
Accounted market size in year	US$ 2672 million
Forecasted market size in 2031	US$ 3943 million
CAGR	5.8%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	0.5G 1.0G
Segment by Application	Hospital Clinic Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	MSD, Shandong New Era Pharmaceuticals, Shenzhen Haibin Pharmaceutical, Sinopharm Guorui Pharmaceutical, Merck Sharp & Dohme Corp., Taiwan Biotech Co., Ltd., Sun Pharmaceutical Industries Ltd., JW PHARMACEUTICAL CORPORATION, Gentle Pharma Co.,Ltd.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Imipenem Astatin Sodium for Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Imipenem Astatin Sodium for Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Imipenem Astatin Sodium for Injection Market growing?

Ans: The Imipenem Astatin Sodium for Injection Market witnessing a CAGR of 5.8% during the forecast period 2025-2031.

What is the Imipenem Astatin Sodium for Injection Market size in 2031?

Ans: The Imipenem Astatin Sodium for Injection Market size in 2031 will be US$ 3943 million.

Who are the main players in the Imipenem Astatin Sodium for Injection Market report?

Ans: The main players in the Imipenem Astatin Sodium for Injection Market are MSD, Shandong New Era Pharmaceuticals, Shenzhen Haibin Pharmaceutical, Sinopharm Guorui Pharmaceutical, Merck Sharp & Dohme Corp., Taiwan Biotech Co., Ltd., Sun Pharmaceutical Industries Ltd., JW PHARMACEUTICAL CORPORATION, Gentle Pharma Co.,Ltd.

What are the Application segmentation covered in the Imipenem Astatin Sodium for Injection Market report?

Ans: The Applications covered in the Imipenem Astatin Sodium for Injection Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Imipenem Astatin Sodium for Injection Market report?

Ans: The Types covered in the Imipenem Astatin Sodium for Injection Market report are 0.5G, 1.0G

1 Imipenem Astatin Sodium for Injection Market Overview

1.1 Product Definition

1.2 Imipenem Astatin Sodium for Injection by Type

1.2.1 Global Imipenem Astatin Sodium for Injection Market Value Comparison by Type (2024 VS 2031)

1.2.2 0.5G

1.2.3 1.0G

1.3 Imipenem Astatin Sodium for Injection by Application

1.3.1 Global Imipenem Astatin Sodium for Injection Market Value by Application (2024 VS 2031)

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Other

1.4 Global Imipenem Astatin Sodium for Injection Market Size Estimates and Forecasts

1.4.1 Global Imipenem Astatin Sodium for Injection Revenue 2020-2031

1.4.2 Global Imipenem Astatin Sodium for Injection Sales 2020-2031

1.4.3 Global Imipenem Astatin Sodium for Injection Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Imipenem Astatin Sodium for Injection Market Competition by Manufacturers

2.1 Global Imipenem Astatin Sodium for Injection Sales Market Share by Manufacturers (2020-2025)

2.2 Global Imipenem Astatin Sodium for Injection Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Imipenem Astatin Sodium for Injection Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Imipenem Astatin Sodium for Injection, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Imipenem Astatin Sodium for Injection, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Imipenem Astatin Sodium for Injection, Product Type & Application

2.7 Global Key Manufacturers of Imipenem Astatin Sodium for Injection, Date of Enter into This Industry

2.8 Global Imipenem Astatin Sodium for Injection Market Competitive Situation and Trends

2.8.1 Global Imipenem Astatin Sodium for Injection Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Imipenem Astatin Sodium for Injection Players Market Share by Revenue

2.8.3 Global Imipenem Astatin Sodium for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Imipenem Astatin Sodium for Injection Market Scenario by Region

3.1 Global Imipenem Astatin Sodium for Injection Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Imipenem Astatin Sodium for Injection Sales by Region: 2020-2031

3.2.1 Global Imipenem Astatin Sodium for Injection Sales by Region: 2020-2025

3.2.2 Global Imipenem Astatin Sodium for Injection Sales by Region: 2026-2031

3.3 Global Imipenem Astatin Sodium for Injection Revenue by Region: 2020-2031

3.3.1 Global Imipenem Astatin Sodium for Injection Revenue by Region: 2020-2025

3.3.2 Global Imipenem Astatin Sodium for Injection Revenue by Region: 2026-2031

3.4 North America Imipenem Astatin Sodium for Injection Market Facts & Figures by Country

3.4.1 North America Imipenem Astatin Sodium for Injection Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Imipenem Astatin Sodium for Injection Sales by Country (2020-2031)

3.4.3 North America Imipenem Astatin Sodium for Injection Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Imipenem Astatin Sodium for Injection Market Facts & Figures by Country

3.5.1 Europe Imipenem Astatin Sodium for Injection Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Imipenem Astatin Sodium for Injection Sales by Country (2020-2031)

3.5.3 Europe Imipenem Astatin Sodium for Injection Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Imipenem Astatin Sodium for Injection Market Facts & Figures by Region

3.6.1 Asia Pacific Imipenem Astatin Sodium for Injection Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Imipenem Astatin Sodium for Injection Sales by Region (2020-2031)

3.6.3 Asia Pacific Imipenem Astatin Sodium for Injection Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Imipenem Astatin Sodium for Injection Market Facts & Figures by Country

3.7.1 Latin America Imipenem Astatin Sodium for Injection Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Imipenem Astatin Sodium for Injection Sales by Country (2020-2031)

3.7.3 Latin America Imipenem Astatin Sodium for Injection Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Imipenem Astatin Sodium for Injection Market Facts & Figures by Country

3.8.1 Middle East and Africa Imipenem Astatin Sodium for Injection Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Imipenem Astatin Sodium for Injection Sales by Country (2020-2031)

3.8.3 Middle East and Africa Imipenem Astatin Sodium for Injection Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Imipenem Astatin Sodium for Injection Sales by Type (2020-2031)

4.1.1 Global Imipenem Astatin Sodium for Injection Sales by Type (2020-2025)

4.1.2 Global Imipenem Astatin Sodium for Injection Sales by Type (2026-2031)

4.1.3 Global Imipenem Astatin Sodium for Injection Sales Market Share by Type (2020-2031)

4.2 Global Imipenem Astatin Sodium for Injection Revenue by Type (2020-2031)

4.2.1 Global Imipenem Astatin Sodium for Injection Revenue by Type (2020-2025)

4.2.2 Global Imipenem Astatin Sodium for Injection Revenue by Type (2026-2031)

4.2.3 Global Imipenem Astatin Sodium for Injection Revenue Market Share by Type (2020-2031)

4.3 Global Imipenem Astatin Sodium for Injection Price by Type (2020-2031)

5 Segment by Application

5.1 Global Imipenem Astatin Sodium for Injection Sales by Application (2020-2031)

5.1.1 Global Imipenem Astatin Sodium for Injection Sales by Application (2020-2025)

5.1.2 Global Imipenem Astatin Sodium for Injection Sales by Application (2026-2031)

5.1.3 Global Imipenem Astatin Sodium for Injection Sales Market Share by Application (2020-2031)

5.2 Global Imipenem Astatin Sodium for Injection Revenue by Application (2020-2031)

5.2.1 Global Imipenem Astatin Sodium for Injection Revenue by Application (2020-2025)

5.2.2 Global Imipenem Astatin Sodium for Injection Revenue by Application (2026-2031)

5.2.3 Global Imipenem Astatin Sodium for Injection Revenue Market Share by Application (2020-2031)

5.3 Global Imipenem Astatin Sodium for Injection Price by Application (2020-2031)

6 Key Companies Profiled

6.1 MSD

6.1.1 MSD Company Information

6.1.2 MSD Description and Business Overview

6.1.3 MSD Imipenem Astatin Sodium for Injection Sales, Revenue and Gross Margin (2020-2025)

6.1.4 MSD Imipenem Astatin Sodium for Injection Product Portfolio

6.1.5 MSD Recent Developments/Updates

6.2 Shandong New Era Pharmaceuticals

6.2.1 Shandong New Era Pharmaceuticals Company Information

6.2.2 Shandong New Era Pharmaceuticals Description and Business Overview

6.2.3 Shandong New Era Pharmaceuticals Imipenem Astatin Sodium for Injection Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Shandong New Era Pharmaceuticals Imipenem Astatin Sodium for Injection Product Portfolio

6.2.5 Shandong New Era Pharmaceuticals Recent Developments/Updates

6.3 Shenzhen Haibin Pharmaceutical

6.3.1 Shenzhen Haibin Pharmaceutical Company Information

6.3.2 Shenzhen Haibin Pharmaceutical Description and Business Overview

6.3.3 Shenzhen Haibin Pharmaceutical Imipenem Astatin Sodium for Injection Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Shenzhen Haibin Pharmaceutical Imipenem Astatin Sodium for Injection Product Portfolio

6.3.5 Shenzhen Haibin Pharmaceutical Recent Developments/Updates

6.4 Sinopharm Guorui Pharmaceutical

6.4.1 Sinopharm Guorui Pharmaceutical Company Information

6.4.2 Sinopharm Guorui Pharmaceutical Description and Business Overview

6.4.3 Sinopharm Guorui Pharmaceutical Imipenem Astatin Sodium for Injection Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Sinopharm Guorui Pharmaceutical Imipenem Astatin Sodium for Injection Product Portfolio

6.4.5 Sinopharm Guorui Pharmaceutical Recent Developments/Updates

6.5 Merck Sharp & Dohme Corp.

6.5.1 Merck Sharp & Dohme Corp. Company Information

6.5.2 Merck Sharp & Dohme Corp. Description and Business Overview

6.5.3 Merck Sharp & Dohme Corp. Imipenem Astatin Sodium for Injection Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Merck Sharp & Dohme Corp. Imipenem Astatin Sodium for Injection Product Portfolio

6.5.5 Merck Sharp & Dohme Corp. Recent Developments/Updates

6.6 Taiwan Biotech Co., Ltd.

6.6.1 Taiwan Biotech Co., Ltd. Company Information

6.6.2 Taiwan Biotech Co., Ltd. Description and Business Overview

6.6.3 Taiwan Biotech Co., Ltd. Imipenem Astatin Sodium for Injection Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Taiwan Biotech Co., Ltd. Imipenem Astatin Sodium for Injection Product Portfolio

6.6.5 Taiwan Biotech Co., Ltd. Recent Developments/Updates

6.7 Sun Pharmaceutical Industries Ltd.

6.7.1 Sun Pharmaceutical Industries Ltd. Company Information

6.7.2 Sun Pharmaceutical Industries Ltd. Description and Business Overview

6.7.3 Sun Pharmaceutical Industries Ltd. Imipenem Astatin Sodium for Injection Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Sun Pharmaceutical Industries Ltd. Imipenem Astatin Sodium for Injection Product Portfolio

6.7.5 Sun Pharmaceutical Industries Ltd. Recent Developments/Updates

6.8 JW PHARMACEUTICAL CORPORATION

6.8.1 JW PHARMACEUTICAL CORPORATION Company Information

6.8.2 JW PHARMACEUTICAL CORPORATION Description and Business Overview

6.8.3 JW PHARMACEUTICAL CORPORATION Imipenem Astatin Sodium for Injection Sales, Revenue and Gross Margin (2020-2025)

6.8.4 JW PHARMACEUTICAL CORPORATION Imipenem Astatin Sodium for Injection Product Portfolio

6.8.5 JW PHARMACEUTICAL CORPORATION Recent Developments/Updates

6.9 Gentle Pharma Co.,Ltd.

6.9.1 Gentle Pharma Co.,Ltd. Company Information

6.9.2 Gentle Pharma Co.,Ltd. Description and Business Overview

6.9.3 Gentle Pharma Co.,Ltd. Imipenem Astatin Sodium for Injection Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Gentle Pharma Co.,Ltd. Imipenem Astatin Sodium for Injection Product Portfolio

6.9.5 Gentle Pharma Co.,Ltd. Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Imipenem Astatin Sodium for Injection Industry Chain Analysis

7.2 Imipenem Astatin Sodium for Injection Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Imipenem Astatin Sodium for Injection Production Mode & Process Analysis

7.4 Imipenem Astatin Sodium for Injection Sales and Marketing

7.4.1 Imipenem Astatin Sodium for Injection Sales Channels

7.4.2 Imipenem Astatin Sodium for Injection Distributors

7.5 Imipenem Astatin Sodium for Injection Customer Analysis

8 Imipenem Astatin Sodium for Injection Market Dynamics

8.1 Imipenem Astatin Sodium for Injection Industry Trends

8.2 Imipenem Astatin Sodium for Injection Market Drivers

8.3 Imipenem Astatin Sodium for Injection Market Challenges

8.4 Imipenem Astatin Sodium for Injection Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

MSD

Shandong New Era Pharmaceuticals

Shenzhen Haibin Pharmaceutical

Sinopharm Guorui Pharmaceutical

Sun Pharmaceutical Industries Ltd.

JW Pharmaceutical Corporation

Gentle Pharma Co.,Ltd.

List of Tables

Table 1. Global Imipenem Astatin Sodium for Injection Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Imipenem Astatin Sodium for Injection Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Imipenem Astatin Sodium for Injection Market Competitive Situation by Manufacturers in 2024

Table 4. Global Imipenem Astatin Sodium for Injection Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Imipenem Astatin Sodium for Injection Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Imipenem Astatin Sodium for Injection Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Imipenem Astatin Sodium for Injection Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Imipenem Astatin Sodium for Injection Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Imipenem Astatin Sodium for Injection, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Imipenem Astatin Sodium for Injection, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Imipenem Astatin Sodium for Injection, Product Type & Application

Table 12. Global Key Manufacturers of Imipenem Astatin Sodium for Injection, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Imipenem Astatin Sodium for Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Imipenem Astatin Sodium for Injection as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Imipenem Astatin Sodium for Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Imipenem Astatin Sodium for Injection Sales by Region (2020-2025) & (K Units)

Table 18. Global Imipenem Astatin Sodium for Injection Sales Market Share by Region (2020-2025)

Table 19. Global Imipenem Astatin Sodium for Injection Sales by Region (2026-2031) & (K Units)

Table 20. Global Imipenem Astatin Sodium for Injection Sales Market Share by Region (2026-2031)

Table 21. Global Imipenem Astatin Sodium for Injection Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Imipenem Astatin Sodium for Injection Revenue Market Share by Region (2020-2025)

Table 23. Global Imipenem Astatin Sodium for Injection Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Imipenem Astatin Sodium for Injection Revenue Market Share by Region (2026-2031)

Table 25. North America Imipenem Astatin Sodium for Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Imipenem Astatin Sodium for Injection Sales by Country (2020-2025) & (K Units)

Table 27. North America Imipenem Astatin Sodium for Injection Sales by Country (2026-2031) & (K Units)

Table 28. North America Imipenem Astatin Sodium for Injection Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Imipenem Astatin Sodium for Injection Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Imipenem Astatin Sodium for Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Imipenem Astatin Sodium for Injection Sales by Country (2020-2025) & (K Units)

Table 32. Europe Imipenem Astatin Sodium for Injection Sales by Country (2026-2031) & (K Units)

Table 33. Europe Imipenem Astatin Sodium for Injection Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Imipenem Astatin Sodium for Injection Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Imipenem Astatin Sodium for Injection Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Imipenem Astatin Sodium for Injection Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Imipenem Astatin Sodium for Injection Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Imipenem Astatin Sodium for Injection Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Imipenem Astatin Sodium for Injection Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Imipenem Astatin Sodium for Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Imipenem Astatin Sodium for Injection Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Imipenem Astatin Sodium for Injection Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Imipenem Astatin Sodium for Injection Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Imipenem Astatin Sodium for Injection Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Imipenem Astatin Sodium for Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Imipenem Astatin Sodium for Injection Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Imipenem Astatin Sodium for Injection Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Imipenem Astatin Sodium for Injection Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Imipenem Astatin Sodium for Injection Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Imipenem Astatin Sodium for Injection Sales (K Units) by Type (2020-2025)

Table 51. Global Imipenem Astatin Sodium for Injection Sales (K Units) by Type (2026-2031)

Table 52. Global Imipenem Astatin Sodium for Injection Sales Market Share by Type (2020-2025)

Table 53. Global Imipenem Astatin Sodium for Injection Sales Market Share by Type (2026-2031)

Table 54. Global Imipenem Astatin Sodium for Injection Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Imipenem Astatin Sodium for Injection Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Imipenem Astatin Sodium for Injection Revenue Market Share by Type (2020-2025)

Table 57. Global Imipenem Astatin Sodium for Injection Revenue Market Share by Type (2026-2031)

Table 58. Global Imipenem Astatin Sodium for Injection Price (US$/Unit) by Type (2020-2025)

Table 59. Global Imipenem Astatin Sodium for Injection Price (US$/Unit) by Type (2026-2031)

Table 60. Global Imipenem Astatin Sodium for Injection Sales (K Units) by Application (2020-2025)

Table 61. Global Imipenem Astatin Sodium for Injection Sales (K Units) by Application (2026-2031)

Table 62. Global Imipenem Astatin Sodium for Injection Sales Market Share by Application (2020-2025)

Table 63. Global Imipenem Astatin Sodium for Injection Sales Market Share by Application (2026-2031)

Table 64. Global Imipenem Astatin Sodium for Injection Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Imipenem Astatin Sodium for Injection Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Imipenem Astatin Sodium for Injection Revenue Market Share by Application (2020-2025)

Table 67. Global Imipenem Astatin Sodium for Injection Revenue Market Share by Application (2026-2031)

Table 68. Global Imipenem Astatin Sodium for Injection Price (US$/Unit) by Application (2020-2025)

Table 69. Global Imipenem Astatin Sodium for Injection Price (US$/Unit) by Application (2026-2031)

Table 70. MSD Company Information

Table 71. MSD Description and Business Overview

Table 72. MSD Imipenem Astatin Sodium for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. MSD Imipenem Astatin Sodium for Injection Product

Table 74. MSD Recent Developments/Updates

Table 75. Shandong New Era Pharmaceuticals Company Information

Table 76. Shandong New Era Pharmaceuticals Description and Business Overview

Table 77. Shandong New Era Pharmaceuticals Imipenem Astatin Sodium for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Shandong New Era Pharmaceuticals Imipenem Astatin Sodium for Injection Product

Table 79. Shandong New Era Pharmaceuticals Recent Developments/Updates

Table 80. Shenzhen Haibin Pharmaceutical Company Information

Table 81. Shenzhen Haibin Pharmaceutical Description and Business Overview

Table 82. Shenzhen Haibin Pharmaceutical Imipenem Astatin Sodium for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. Shenzhen Haibin Pharmaceutical Imipenem Astatin Sodium for Injection Product

Table 84. Shenzhen Haibin Pharmaceutical Recent Developments/Updates

Table 85. Sinopharm Guorui Pharmaceutical Company Information

Table 86. Sinopharm Guorui Pharmaceutical Description and Business Overview

Table 87. Sinopharm Guorui Pharmaceutical Imipenem Astatin Sodium for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. Sinopharm Guorui Pharmaceutical Imipenem Astatin Sodium for Injection Product

Table 89. Sinopharm Guorui Pharmaceutical Recent Developments/Updates

Table 90. Merck Sharp & Dohme Corp. Company Information

Table 91. Merck Sharp & Dohme Corp. Description and Business Overview

Table 92. Merck Sharp & Dohme Corp. Imipenem Astatin Sodium for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. Merck Sharp & Dohme Corp. Imipenem Astatin Sodium for Injection Product

Table 94. Merck Sharp & Dohme Corp. Recent Developments/Updates

Table 95. Taiwan Biotech Co., Ltd. Company Information

Table 96. Taiwan Biotech Co., Ltd. Description and Business Overview

Table 97. Taiwan Biotech Co., Ltd. Imipenem Astatin Sodium for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. Taiwan Biotech Co., Ltd. Imipenem Astatin Sodium for Injection Product

Table 99. Taiwan Biotech Co., Ltd. Recent Developments/Updates

Table 100. Sun Pharmaceutical Industries Ltd. Company Information

Table 101. Sun Pharmaceutical Industries Ltd. Description and Business Overview

Table 102. Sun Pharmaceutical Industries Ltd. Imipenem Astatin Sodium for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. Sun Pharmaceutical Industries Ltd. Imipenem Astatin Sodium for Injection Product

Table 104. Sun Pharmaceutical Industries Ltd. Recent Developments/Updates

Table 105. JW PHARMACEUTICAL CORPORATION Company Information

Table 106. JW PHARMACEUTICAL CORPORATION Description and Business Overview

Table 107. JW PHARMACEUTICAL CORPORATION Imipenem Astatin Sodium for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 108. JW PHARMACEUTICAL CORPORATION Imipenem Astatin Sodium for Injection Product

Table 109. JW PHARMACEUTICAL CORPORATION Recent Developments/Updates

Table 110. Gentle Pharma Co.,Ltd. Company Information

Table 111. Gentle Pharma Co.,Ltd. Description and Business Overview

Table 112. Gentle Pharma Co.,Ltd. Imipenem Astatin Sodium for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 113. Gentle Pharma Co.,Ltd. Imipenem Astatin Sodium for Injection Product

Table 114. Gentle Pharma Co.,Ltd. Recent Developments/Updates

Table 115. Key Raw Materials Lists

Table 116. Raw Materials Key Suppliers Lists

Table 117. Imipenem Astatin Sodium for Injection Distributors List

Table 118. Imipenem Astatin Sodium for Injection Customers List

Table 119. Imipenem Astatin Sodium for Injection Market Trends

Table 120. Imipenem Astatin Sodium for Injection Market Drivers

Table 121. Imipenem Astatin Sodium for Injection Market Challenges

Table 122. Imipenem Astatin Sodium for Injection Market Restraints

Table 123. Research Programs/Design for This Report

Table 124. Key Data Information from Secondary Sources

Table 125. Key Data Information from Primary Sources

Table 126. Authors List of This Report

List of Figures

Figure 1. Product Picture of Imipenem Astatin Sodium for Injection

Figure 2. Global Imipenem Astatin Sodium for Injection Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Imipenem Astatin Sodium for Injection Market Share by Type: 2024 & 2031

Figure 4. 0.5G Product Picture

Figure 5. 1.0G Product Picture

Figure 6. Global Imipenem Astatin Sodium for Injection Market Value by Application (2020-2031) & (US$ Million)

Figure 7. Global Imipenem Astatin Sodium for Injection Market Share by Application: 2024 & 2031

Figure 8. Hospital

Figure 9. Clinic

Figure 10. Other

Figure 11. Global Imipenem Astatin Sodium for Injection Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global Imipenem Astatin Sodium for Injection Market Size (2020-2031) & (US$ Million)

Figure 13. Global Imipenem Astatin Sodium for Injection Sales (2020-2031) & (K Units)

Figure 14. Global Imipenem Astatin Sodium for Injection Average Price (US$/Unit) & (2020-2031)

Figure 15. Imipenem Astatin Sodium for Injection Report Years Considered

Figure 16. Imipenem Astatin Sodium for Injection Sales Share by Manufacturers in 2024

Figure 17. Global Imipenem Astatin Sodium for Injection Revenue Share by Manufacturers in 2024

Figure 18. Global 5 and 10 Largest Imipenem Astatin Sodium for Injection Players: Market Share by Revenue in Imipenem Astatin Sodium for Injection in 2024

Figure 19. Imipenem Astatin Sodium for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 20. Global Imipenem Astatin Sodium for Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 21. North America Imipenem Astatin Sodium for Injection Sales Market Share by Country (2020-2031)

Figure 22. North America Imipenem Astatin Sodium for Injection Revenue Market Share by Country (2020-2031)

Figure 23. United States Imipenem Astatin Sodium for Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 24. Canada Imipenem Astatin Sodium for Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Europe Imipenem Astatin Sodium for Injection Sales Market Share by Country (2020-2031)

Figure 26. Europe Imipenem Astatin Sodium for Injection Revenue Market Share by Country (2020-2031)

Figure 27. Germany Imipenem Astatin Sodium for Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. France Imipenem Astatin Sodium for Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. U.K. Imipenem Astatin Sodium for Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Italy Imipenem Astatin Sodium for Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Russia Imipenem Astatin Sodium for Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Asia Pacific Imipenem Astatin Sodium for Injection Sales Market Share by Region (2020-2031)

Figure 33. Asia Pacific Imipenem Astatin Sodium for Injection Revenue Market Share by Region (2020-2031)

Figure 34. China Imipenem Astatin Sodium for Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Japan Imipenem Astatin Sodium for Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. South Korea Imipenem Astatin Sodium for Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. India Imipenem Astatin Sodium for Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Australia Imipenem Astatin Sodium for Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. China Taiwan Imipenem Astatin Sodium for Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Southeast Asia Imipenem Astatin Sodium for Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Latin America Imipenem Astatin Sodium for Injection Sales Market Share by Country (2020-2031)

Figure 42. Latin America Imipenem Astatin Sodium for Injection Revenue Market Share by Country (2020-2031)

Figure 43. Mexico Imipenem Astatin Sodium for Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Brazil Imipenem Astatin Sodium for Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Argentina Imipenem Astatin Sodium for Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Middle East and Africa Imipenem Astatin Sodium for Injection Sales Market Share by Country (2020-2031)

Figure 47. Middle East and Africa Imipenem Astatin Sodium for Injection Revenue Market Share by Country (2020-2031)

Figure 48. Turkey Imipenem Astatin Sodium for Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Saudi Arabia Imipenem Astatin Sodium for Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. UAE Imipenem Astatin Sodium for Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Global Sales Market Share of Imipenem Astatin Sodium for Injection by Type (2020-2031)

Figure 52. Global Revenue Market Share of Imipenem Astatin Sodium for Injection by Type (2020-2031)

Figure 53. Global Imipenem Astatin Sodium for Injection Price (US$/Unit) by Type (2020-2031)

Figure 54. Global Sales Market Share of Imipenem Astatin Sodium for Injection by Application (2020-2031)

Figure 55. Global Revenue Market Share of Imipenem Astatin Sodium for Injection by Application (2020-2031)

Figure 56. Global Imipenem Astatin Sodium for Injection Price (US$/Unit) by Application (2020-2031)

Figure 57. Imipenem Astatin Sodium for Injection Value Chain

Figure 58. Channels of Distribution (Direct Vs Distribution)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions